BridgeMD
New treatment option for Type 2 Diabetes Mellitus (T2DM)
Official title CGM for Insulin-Treated T2DM During Post-Discharge Transition
ClinicalTrials.gov ID: NCT07414277
What this study is testing
- What it's testing
- The transition from inpatient care to the home setting is a critical phase for glycemic management, often associated with decreased adherence and deterioration of glycemic control. This multicenter, randomized, open-label, controlled trial aims to evaluate the efficacy of Real-Time Continuous Glucose Monitoring (RT-CGM) versus Self-Monitoring of Blood Glucose (SMBG) in patients with Type 2 Diabetes Mellitus (T2DM) treated with insulin during the post-discharge transitional period.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age 18 to 80 years (inclusive).
- Confirmed diagnosis of type 2 diabetes mellitus (T2DM).
- HbA1c between 8.0% and 13.0% (inclusive) within the last 1 month prior to screening/enrollment.
- Planned to receive insulin therapy for at least 6 months after hospital discharge, as assessed/confirmed by the treating physician (principal...
You likely can't join if
- Current use of a real-time continuous glucose monitoring (RT-CGM) device, or use within the 3 months prior to enrollment.
- Severe skin disease at the sensor insertion site, or allergy to adhesive tape/adhesives.
- Pregnant women; positive pregnancy test at screening; or planning pregnancy during the study period.
- Currently participating in, or planning to participate in, another clinical trial.
- Current use of oral corticosteroid therapy, or anticipated use during the trial period.
- Severe liver disease, defined as alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>3 times the upper limit of normal (ULN).
See the full eligibility criteria
- Age 18 to 80 years (inclusive).
- Confirmed diagnosis of type 2 diabetes mellitus (T2DM).
- HbA1c between 8.0% and 13.0% (inclusive) within the last 1 month prior to screening/enrollment.
- Planned to receive insulin therapy for at least 6 months after hospital discharge, as assessed/confirmed by the treating physician (principal physician).
- Current use of a real-time continuous glucose monitoring (RT-CGM) device, or use within the 3 months prior to enrollment.
- Severe skin disease at the sensor insertion site, or allergy to adhesive tape/adhesives.
- Pregnant women; positive pregnancy test at screening; or planning pregnancy during the study period.
- Currently participating in, or planning to participate in, another clinical trial.
- Current use of oral corticosteroid therapy, or anticipated use during the trial period.
- Severe liver disease, defined as alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>3 times the upper limit of normal (ULN).
- Severe renal impairment or end-stage renal disease, defined as estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m².
- Any condition that, in the investigator's opinion, makes the participant unsuitable for the trial, for example: history of ocular trauma or other diagnosed eye diseases causing visual impairment; unwillingness to...
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.